堕胎药争议升级至最高法院,制造商警告裁决后将现“混乱”


2026年5月2日 美国东部夏令时下午4:44 / 福克斯新闻

塞缪尔·阿利托大法官负责处理来自第五巡回上诉法院的紧急事务,可单独采取行动或将案件提交全体大法官审理

作者:贾斯敏·贝尔 福克斯新闻
发布于2026年5月2日 美国东部夏令时下午4:44

新功能:您现在可以收听福克斯新闻的文章!

收听本文
时长:3分钟

周六,堕胎药的法律争端升级至美国最高法院,米非司酮的制造商提交了一份紧急请求,警告下级法院的裁决已在全美引发“直接混乱和动荡”。

丹科实验室正请求高等法院迅速叫停美国第五巡回上诉法院的一项裁决,该裁决阻断了邮寄购药渠道,恢复了该药物必须当面开具的要求。该公司辩称,此项裁决扰乱了药品供应,并在全美范围内造成了合法性的不确定性。

这项裁决直接影响到丹科的核心产品米非司酮的分销。

米非司酮是药物流产常用的两种药物之一。

这份申请被提交给塞缪尔·阿利托大法官,他负责处理来自第五巡回上诉法院的紧急事务,既可以单独采取行动,也可以将该请求提交给全体大法官。最高法院可随时采取行动。

堕胎药米非司酮引发新的反堕胎争议,部分医生强调安全隐患

米非司酮药盒,用于药物流产。(伊夫林·霍克斯坦/路透社,资料图)

在提交的文件中,丹科警告称,上诉法院的命令已经在现实医疗环境中造成了“混乱”。

“该合议庭的裁决给高度依赖时间的医疗决策带来了直接的混乱和动荡,”该公司写道,并补充说,这正迫使“医护人员、患者和药房都在猜测哪些行为是被允许的,哪些不是。”

这份文件立即引发了诸多疑问,包括现有的堕胎药处方、药房配药以及当面就诊的渠道将如何处理。

反堕胎团体发现拜登时代的FDA政策导致每日500例堕胎,称特朗普有权终止该政策

反堕胎示威者在华盛顿特区年度“生命游行”集会期间,在美国最高法院大楼前举着横幅。(伊夫林·霍克斯坦/路透社,资料图)

“本周末患者如约前往就诊……或走进药房……获取昨天刚开的处方药时,会发生什么?”文件中写道。

丹科请求法院立即通过行政暂停令叫停该裁决,随后在诉讼继续期间长期阻止该裁决生效。该公司还建议大法官们可在本任期结束前加快审理此案,此举可能重塑最高法院本已排满的2026年日程表。

就在第五巡回上诉法院发布裁决的一天后,这项紧急上诉被提交。该裁决阻断了米非司酮的邮寄渠道,并根据受到质疑的FDA规定, effectively barred pharmacy distribution,要求女性必须当面从医护人员处获取该药物。

多布斯案三年后,反堕胎运动面临高堕胎率问题

佛罗里达州一则宣传堕胎药米非司酮和米索前列醇的广告。(“生命40天”组织供图)

“他们当然提交了紧急请愿书。在对这些危险堕胎药进行前所未有的激进放松管制后,制药巨头赚得盆满钵满,”“生命40天”组织主席肖恩·卡尼告诉福克斯新闻数字频道。

“就在几年前,没有任何堕胎支持人士或制药巨头主张通过邮寄方式寄送这些药物,而现在他们却表现得仿佛有权不受任何监管和监督地这么做,”卡尼补充道。“这进一步证明,在多年来因服用这些药物而前往急诊室的女性之后,FDA需要重新评估这些药物的审批方式。”

堕胎权倡导者表示,该裁决已在全美范围内“颠覆”了医疗服务的可及性,尤其是对于依赖远程医疗的患者;而法律团体警告称,这给试图遵守快速变化的规则的医护人员造成了困惑。

纽约州总检察长莱蒂西亚·詹姆斯表示,这项裁决是“又一次对堕胎服务权的残酷攻击”,并补充说“米非司酮安全、有效且必不可少”。

点击此处下载福克斯新闻应用程序

下级法院的核心案件仍在审理中,但此次紧急申请将这场争端直接提交至最高法院,这可能成为堕胎政策方面下一次重大的法律对决。

大法官们可以选择立即暂停该裁决,让现行制度维持不变,同时推进案件审理,也可以让这些限制措施在全美范围内生效。

丹科实验室未立即回应福克斯新闻数字频道的置评请求。

贾斯敏·贝尔是福克斯新闻数字频道的突发新闻撰稿人,报道政治、军事、信仰和文化领域。

Abortion pill fight heads to Supreme Court as manufacturer warns of ‘chaos’ after ruling

2026-05-02 4:44pm EDT / Fox News

Justice Samuel Alito handles emergency matters from the 5th Circuit and can act alone or refer to the full court

By Jasmine Baehr Fox News

Published May 2, 2026 4:44pm EDT

NEW You can now listen to Fox News articles!

Listen to this article

3 min

The legal battle over abortion pills escalated to the Supreme Court on Saturday, as the manufacturer of mifepristone filed an emergency request warning a lower court ruling is already causing “immediate confusion and upheaval” across the country.

Danco Laboratories is asking the high court to quickly block a 5th U.S. Circuit Court of Appeals decision that blocked mail-order access and reinstated in-person requirements for the drug, arguing the ruling is disrupting access and creating nationwide uncertainty about legality.

The ruling directly affects the distribution of mifepristone, Danco’s primary product.

Mifepristone is one of two drugs commonly used in medication abortions.

The application was directed to Justice Samuel Alito, who handles emergency matters from the 5th Circuit and can either act on his own or refer the request to the full court. The Supreme Court could act at any time.

ABORTION PILL MIFEPRISTONE SPARKS NEW PRO-LIFE DEBATE AS SOME DOCTORS STRESS SAFETY CONCERNS

Boxes of mifepristone, a pill used for medical abortions.(Evelyn Hockstein/Reuters, File)

In its filing, Danco warned the appeals court’s order is already creating “chaos” in real-world medical settings.

“The panel’s ruling injects immediate confusion and upheaval into highly time-sensitive medical decisions,” the company wrote, adding it is forcing “providers, patients, and pharmacies all to guess at what is allowed and what is not.”

The filing raises immediate questions, including what happens to existing abortion pill prescriptions, pharmacy dispensing and access to in-person visits.

PRO-LIFE GROUP FINDS BIDEN-ERA FDA POLICY IS DRIVING 500 ABORTIONS PER DAY, SAYS TRUMP HAS POWER TO END IT

Pro-life demonstrators hold a banner in front of the U.S. Supreme Court building during the annual March for Life rally in Washington, D.C.(Evelyn Hockstein/Reuters, File)

“What happens when patients arrive for scheduled appointments this weekend… or walk into pharmacies… to obtain the drug that was prescribed… yesterday?” the filing states.

Danco is asking the court to immediately pause the ruling through an administrative stay, then block it longer term while litigation continues. The company also suggested the justices could take up the case on an expedited schedule before the end of the term, a move that could reshape the court’s already packed 2026 docket.

The emergency appeal comes just one day after the 5th Circuit issued its ruling, which blocked the mailing of mifepristone and effectively barred pharmacy distribution under the challenged FDA rules, requiring women to obtain the drug in-person from a medical provider.

PRO-LIFE MOVEMENT CONFRONTS HIGH ABORTION RATES THREE YEARS AFTER DOBBS

An advertisement promoting the abortion pills mifepristone and misoprostol in Florida.(40 Days for Life)

“Of course they filed an emergency petition. Big Pharma has gotten extremely rich after the unprecedented and radical deregulation of these dangerous abortion pills,” 40 Days for Life President Shawn Carney told Fox News Digital.

“No abortion advocate or anyone from Big Pharma was pushing to send these drugs through the mail just a few years ago, and now they act as if they’re entitled to do so with zero regulation and zero oversight,” Carney added. “This is more evidence the FDA needs to reevaluate how these drugs were approved after years of ER visits from women who take them.”

Abortion-rights advocates said the ruling has “upended” access to care nationwide, particularly for patients relying on telemedicine, while legal groups warned it is creating confusion for providers trying to comply with rapidly changing rules.

New York Attorney General Letitia James said the decision is “yet another cruel attack on abortion access,” adding that “mifepristone is safe, effective, and essential.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

The underlying case is still ongoing in lower courts, but the emergency filing now places the dispute squarely before the Supreme Court in what could become the next major legal showdown over abortion policy.

The justices could choose to pause the ruling immediately, allowing the current system to remain in place while the case proceeds, or let the restrictions take effect nationwide.

Danco Laboratories did not immediately respond to Fox News Digital’s request for comment.

Jasmine Baehr is a Breaking News Writer for Fox News Digital, where she covers politics, the military, faith and culture.

评论

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注